Basilea Pharmaceutica AG carries a market capitalization of 746.00M, placing it among publicly traded companies globally.
| Market Cap | 746.00M |
| Enterprise Value | N/A |
Basilea Pharmaceutica AG's stock has declined approximately -1.73622% over the past 52 weeks. The 50-day moving average sits at 67.99, while the 200-day moving average is 62.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | -1.73622% |
| 50-Day Moving Average | 67.99 |
| 200-Day Moving Average | 62.85 |
| Average Volume (20 Days) | N/A |